| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.12 | 9e-05 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.001 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.094 | 0.003 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.003 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.003 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |